Join
Live feed
·
INSIDERFilingvia Quantisnow
Ambrx Biopharma Inc. logo

SEC Form 4: Cormorant Asset Management, Lp bought $19,625,601 worth of Ordinary Shares (2,152,738 units at $9.12)

ByQuantisnow·Wall Street's wire, on your screen.
AMAM· Ambrx Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMAM (Ambrx Biopharma Inc.) and more on Quantisnow.